252 related articles for article (PubMed ID: 31227381)
21. Fluoroquinolones or macrolides alone versus combined with β-lactams for adults with community-acquired pneumonia: Systematic review and meta-analysis.
Raz-Pasteur A; Shasha D; Paul M
Int J Antimicrob Agents; 2015 Sep; 46(3):242-8. PubMed ID: 26092096
[TBL] [Abstract][Full Text] [Related]
22. Effect of Combined β-Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community-Acquired Pneumonia.
Ceccato A; Cilloniz C; Martin-Loeches I; Ranzani OT; Gabarrus A; Bueno L; Garcia-Vidal C; Ferrer M; Niederman MS; Torres A
Chest; 2019 Apr; 155(4):795-804. PubMed ID: 30471269
[TBL] [Abstract][Full Text] [Related]
23. Antibiotic treatment outcomes in community-acquired pneumonia.
Çilli A; Sayıner A; Çelenk B; Şakar Coşkun A; Kılınç O; Hazar A; Aktaş Samur A; Taşbakan S; Waterer GW; Havlucu Y; Kılıç Ö; Tokgöz F; Bilge U
Turk J Med Sci; 2018 Aug; 48(4):730-736. PubMed ID: 30119147
[TBL] [Abstract][Full Text] [Related]
24. Is β-Lactam Plus Macrolide More Effective than β-Lactam Plus Fluoroquinolone among Patients with Severe Community-Acquired Pneumonia?: a Systemic Review and Meta-Analysis.
Lee JH; Kim HJ; Kim YH
J Korean Med Sci; 2017 Jan; 32(1):77-84. PubMed ID: 27914135
[TBL] [Abstract][Full Text] [Related]
25. Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone.
García Vázquez E; Mensa J; Martínez JA; Marcos MA; Puig J; Ortega M; Torres A
Eur J Clin Microbiol Infect Dis; 2005 Mar; 24(3):190-5. PubMed ID: 15782278
[TBL] [Abstract][Full Text] [Related]
26. Additional effect of azithromycin over β-lactam alone for severe community-acquired pneumonia-associated acute respiratory distress syndrome: a retrospective cohort study.
Suzuki J; Sasabuchi Y; Hatakeyama S; Matsui H; Sasahara T; Morisawa Y; Yamada T; Fushimi K; Yasunaga H
Pneumonia (Nathan); 2022 Jan; 14(1):1. PubMed ID: 35012674
[TBL] [Abstract][Full Text] [Related]
27. Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial.
Postma DF; Spitoni C; van Werkhoven CH; van Elden LJR; Oosterheert JJ; Bonten MJM
BMC Infect Dis; 2019 Jan; 19(1):17. PubMed ID: 30612559
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of Macrolide Deescalation in Severe Community-acquired Pneumonia.
Hopkins TM; Juang P; Weaver K; Kollef MH; Betthauser KD
Clin Ther; 2019 Dec; 41(12):2540-2548. PubMed ID: 31676040
[TBL] [Abstract][Full Text] [Related]
29. Comparison of two guideline-concordant antimicrobial combinations in elderly patients hospitalized with severe community-acquired pneumonia.
Wilson BZ; Anzueto A; Restrepo MI; Pugh MJ; Mortensen EM
Crit Care Med; 2012 Aug; 40(8):2310-4. PubMed ID: 22622401
[TBL] [Abstract][Full Text] [Related]
30. Comparative effectiveness of empiric β-lactam monotherapy and β-lactam-macrolide combination therapy in children hospitalized with community-acquired pneumonia.
Ambroggio L; Taylor JA; Tabb LP; Newschaffer CJ; Evans AA; Shah SS
J Pediatr; 2012 Dec; 161(6):1097-103. PubMed ID: 22901738
[TBL] [Abstract][Full Text] [Related]
31. Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: impact on survival and bacterial resistance.
Adrie C; Schwebel C; Garrouste-Orgeas M; Vignoud L; Planquette B; Azoulay E; Kallel H; Darmon M; Souweine B; Dinh-Xuan AT; Jamali S; Zahar JR; Timsit JF;
Crit Care; 2013 Nov; 17(6):R265. PubMed ID: 24200097
[TBL] [Abstract][Full Text] [Related]
32. Antibiotic treatment patterns, costs, and resource utilization among patients with community acquired pneumonia: a US cohort study.
Llop CJ; Tuttle E; Tillotson GS; LaPlante K; File TM
Hosp Pract (1995); 2017 Feb; 45(1):1-8. PubMed ID: 28064542
[TBL] [Abstract][Full Text] [Related]
33. Community-Acquired Pneumonia in Adults: Diagnosis and Management.
Kaysin A; Viera AJ
Am Fam Physician; 2016 Nov; 94(9):698-706. PubMed ID: 27929242
[TBL] [Abstract][Full Text] [Related]
34. Mortality in patients with community-onset pneumonia at low risk of drug-resistant pathogens: Impact of β-lactam plus macrolide combination therapy.
Okumura J; Shindo Y; Takahashi K; Sano M; Sugino Y; Yagi T; Taniguchi H; Saka H; Matsui S; Hasegawa Y;
Respirology; 2018 May; 23(5):526-534. PubMed ID: 29239493
[TBL] [Abstract][Full Text] [Related]
35. Fluoroquinolones or macrolides in combination with β-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis.
Vardakas KZ; Trigkidis KK; Falagas ME
Clin Microbiol Infect; 2017 Apr; 23(4):234-241. PubMed ID: 27965070
[TBL] [Abstract][Full Text] [Related]
36. Role of beta-lactam agents in the treatment of community-acquired pneumonia.
Garau J
Eur J Clin Microbiol Infect Dis; 2005 Feb; 24(2):83-99. PubMed ID: 15696306
[TBL] [Abstract][Full Text] [Related]
37. β-Lactams plus doxycycline versus azithromycin for treatment of severe community-acquired pneumonia in critically ill patients.
Greco Kinney A; Kovacic Scherrer N; Sarkar S; Jain P; Wen S; Hadique S
J Antimicrob Chemother; 2023 Dec; 78(12):2816-2823. PubMed ID: 37814829
[TBL] [Abstract][Full Text] [Related]
38. Comparative Treatment Failure Rates of Respiratory Fluoroquinolones or β-Lactam + Macrolide Versus β-Lactam Alone in the Treatment for Community-Acquired Pneumonia in Adult Outpatients: An Analysis of a Nationally Representative Claims Database.
Lee MG; Lee SH; Chang SS; Chan YL; Pang L; Hsu SM; Lee CC
Medicine (Baltimore); 2015 Sep; 94(39):e1662. PubMed ID: 26426664
[TBL] [Abstract][Full Text] [Related]
39. Beta-lactam plus macrolides or beta-lactam alone for community-acquired pneumonia: A systematic review and meta-analysis.
Horita N; Otsuka T; Haranaga S; Namkoong H; Miki M; Miyashita N; Higa F; Takahashi H; Yoshida M; Kohno S; Kaneko T
Respirology; 2016 Oct; 21(7):1193-200. PubMed ID: 27338144
[TBL] [Abstract][Full Text] [Related]
40. Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic review.
Al-Salloum J; Gillani SW; Mahmood RK; Gulam SM
J Int Med Res; 2021 Oct; 49(10):3000605211049943. PubMed ID: 34719987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
